EntityQ265831· pop 23· linked from 866 articles

cannabinol

Cannabinol (CBN) is a mildly psychoactive phytocannabinoid that acts as a low affinity partial agonist at the CB1 and CB2 receptors of the endocannabinoid system (ECS).

Key facts

Drug.Verifiedfields: changed
Drug.Watchedfields: changed
Drug.verifiedrevid: 477165540
Drug.image: Cannabinol-2D-skeletal.svg
Drug.image_class: skin-invert-image
Drug.width: 250px
Drug.image2: Cannabinol 3D.png
Drug.image_class2: bg-transparent
Drug.width2: 200px
Drug.legal_CA: Unscheduled
Drug.legal_UK: Class B
Drug.legal_US: Unscheduled
Drug.IUPAC_name: 6,6,9-Trimethyl-3-pentyl-benzo[c]chromen-1-ol
Drug.C: 21
Drug.H: 26
Drug.O: 2
Drug.SMILES: Oc2cc(cc1OC(c3c(c12)cc(cc3)C)(C)C)CCCCC
Drug.StdInChI: 1S/C21H26O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h9-13,22H,5-8H2,1-4H3

via Wikipedia infobox

Article

14 sections

Contents

Pharmacology
Pharmacodynamics
Putative receptor targets
Neurotransmitter interactions
Pharmacokinetics
Chemistry
Chemical structure
History
Society and culture
Legal status
United States
Biosynthesis
References
External links

Cannabinol (CBN) is a mildly psychoactive phytocannabinoid that acts as a low affinity partial agonist at the CB1 and CB2 receptors of the endocannabinoid system (ECS).

Although CBN shares the same mechanism of action as other phytocannabinoids such as tetrahydrocannabinol (THC), it has a lower affinity for CB1 receptors, meaning that much higher doses of CBN are required in order to experience intoxicating effects.